Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the localization of and results in increased activity of FOXO3 protein | affects localization|increases activity | 19211844
|
C026137 |
3-hydroxyacetanilide |
3-hydroxyacetanilide results in decreased expression of FOXO3 mRNA | decreases expression | 18544908
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of FOXO3 mRNA | decreases expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of FOXO3 mRNA | increases expression | 18544908
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of FOXO3 mRNA | decreases expression | 20106945
|
D004317 |
Doxorubicin |
BIRC5 protein inhibits the reaction [FOXO3 protein results in increased susceptibility to Doxorubicin] | decreases reaction|increases response to substance | 19211844
|
D004317 |
Doxorubicin |
Doxorubicin results in increased phosphorylation of FOXO3 protein | increases phosphorylation | 17935137
|
D004317 |
Doxorubicin |
[FOXO3 protein results in decreased expression of BIRC5 protein] which results in increased susceptibility to Doxorubicin | decreases expression|increases response to substance | 19211844
|
D004317 |
Doxorubicin |
FOXO3 protein results in increased susceptibility to Doxorubicin | increases response to substance | 19211844
|
D004317 |
Doxorubicin |
wortmannin inhibits the reaction [Doxorubicin results in increased phosphorylation of FOXO3 protein] | decreases reaction|increases phosphorylation | 17935137
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of FOXO3 mRNA | decreases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of FOXO3 mRNA | affects cotreatment|decreases expression | 17942748
|
D005047 |
Etoposide |
BIRC5 protein inhibits the reaction [FOXO3 protein results in increased susceptibility to Etoposide] | decreases reaction|increases response to substance | 19211844
|
D005047 |
Etoposide |
Etoposide results in increased phosphorylation of FOXO3 protein | increases phosphorylation | 17935137
|
D005047 |
Etoposide |
[FOXO3 protein results in decreased expression of BIRC5 protein] which results in increased susceptibility to Etoposide | decreases expression|increases response to substance | 19211844
|
D005047 |
Etoposide |
FOXO3 protein results in increased susceptibility to Etoposide | increases response to substance | 19211844
|
D005047 |
Etoposide |
wortmannin inhibits the reaction [Etoposide results in increased phosphorylation of FOXO3 protein] | decreases reaction|increases phosphorylation | 17935137
|
D005472 |
Fluorouracil |
FOXO3 affects the susceptibility to Fluorouracil | affects response to substance | 15067352
|
D019833 |
Genistein |
Genistein affects the expression of FOXO3 mRNA | affects expression | 18431742
|
D019833 |
Genistein |
Genistein affects the expression of FOXO3 protein | affects expression | 18431742
|
D019833 |
Genistein |
Genistein affects the localization of FOXO3 protein | affects localization | 18431742
|
D019833 |
Genistein |
Genistein inhibits the reaction [HIST3H3 protein modified form binds to FOXO3 promoter] | affects binding|decreases reaction | 18431742
|
D019833 |
Genistein |
Genistein inhibits the reaction [SIRT1 protein binds to FOXO3 promoter] | affects binding|decreases reaction | 18431742
|
D019833 |
Genistein |
Genistein results in decreased phosphorylation of FOXO3 protein | decreases phosphorylation | 18431742
|
D019833 |
Genistein |
[[Genistein results in increased expression of PTEN protein] which results in decreased activity of AKT1 protein] which results in increased activity of FOXO3 protein | decreases activity|increases activity|increases expression | 18431742
|
D007529 |
Isoflavones |
Isoflavones results in increased expression of FOXO3 mRNA | increases expression | 17374662
|
D007529 |
Isoflavones |
Isoflavones results in increased expression of FOXO3 protein | increases expression | 17374662
|
C533894 |
LG 100815 |
LG 100815 results in increased expression of FOXO3 mRNA | increases expression | 16951191
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased phosphorylation of and results in increased activity of FOXO3 protein | decreases phosphorylation|increases activity | 17339365
|
C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in increased expression of FOXO3 mRNA | increases expression | 16951191
|
C059514 |
resveratrol |
resveratrol affects the localization of and results in increased activity of FOXO3 protein | affects localization|increases activity | 17513867
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of FOXO3 protein] | decreases reaction|increases phosphorylation | 17513867
|
C059514 |
resveratrol |
resveratrol promotes the reaction [FOXO3 protein binds to CDKN1B promoter] | affects binding|increases reaction | 17513867
|
C059514 |
resveratrol |
resveratrol promotes the reaction [FOXO3 protein binds to FASLG promoter] | affects binding|increases reaction | 17513867
|
D012643 |
Selenium |
Selenium results in decreased phosphorylation of and results in increased activity of FOXO3 protein | decreases phosphorylation|increases activity | 17339365
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of FOXO3 mRNA | affects expression | 19590694
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of FOXO3 mRNA | affects cotreatment|decreases expression | 17942748
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of FOXO3 mRNA | decreases expression | 19101580
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [Doxorubicin results in increased phosphorylation of FOXO3 protein] | decreases reaction|increases phosphorylation | 17935137
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [Etoposide results in increased phosphorylation of FOXO3 protein] | decreases reaction|increases phosphorylation | 17935137
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.03 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.03 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.84 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.86 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.77 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
10.02 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
10.02 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
10.02 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
10.02 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.67 | 3712494 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.67 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.62 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.82 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.46 | 21441931 |
MESH:D000505 |
Alopecia |
|
Isoflavones |
4.65 | 17569567 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.55 | 16183991 16162502 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.42 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.42 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.76 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.50 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.38 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.18 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.18 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.22 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 17507914 19460635 18396377 18775368 20603192 16609825 18316065 18177632 18940202 17688650 18985861 19232924 15238991 17157402 18558336 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.94 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.03 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.96 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.83 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.83 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
11.89 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
11.89 | 14601052 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.20 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.73 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.93 | 15939500 18234424 15136595 18382427 19526202 16115903 18628466 16595493 16264153 15634643 16096432 16322301 15993339 17983394 18695136 17426702 16826403 16935488 15692762 15994142 17369602 15668708 11325840 15567936 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
2.93 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.93 | 18608205 16595493 19217205 16110121 15136595 16557594 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.93 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.93 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.93 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.08 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
12.08 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.95 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.95 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
13.89 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
13.89 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
13.89 | 18059187 16023760 16234567 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
13.89 | 17971768 16799960 18930000 17045692 17088986 16332177 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
13.89 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
13.89 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
13.89 | 16507464 15276417 17306315 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.51 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
10.55 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.55 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
10.55 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.63 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
10.63 | 16757204 16280240 17066447 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
10.63 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.63 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.32 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.47 | 17924179 17351982 17928571 16651473 17382496 16269455 16455267 15505089 15792986 16731534 15811867 17308081 16952015 17519947 16242529 18627295 16278810 16364871 17007740 15476868 16612575 17974986 17131338 16109756 17329180 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.92 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
11.99 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
11.99 | 17689850 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
11.99 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.53 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
10.81 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.81 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.81 | 19524636 20056578 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.68 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.08 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
13.00 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.00 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.00 | 16105132 11677210 17681005 15861022 16919318 17333356 17110522 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.07 | 15340226 12621046 8697196 15668235 16354765 |
MESH:D003092 |
Colitis |
|
resveratrol |
9.36 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
9.36 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.81 | 18772588 16340194 17287894 16510598 17016597 15001691 17172411 17725105 17018589 17169374 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.81 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.81 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.80 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.80 | 17094418 15148649 17594712 17454858 18288408 16524972 15289873 20501625 18949393 17695437 14970324 18383874 17016601 16282729 16391804 16303861 18448328 18509181 17255274 18802399 16331619 17401013 |
MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
4.80 | 17116718 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
4.80 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.69 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.45 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.45 | 17688650 8888407 16575769 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.71 | 16733453 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.72 | 12868966 11298694 8156756 8970840 18759878 11906362 14531868 2524372 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.41 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.69 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.26 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.26 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.89 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
14.93 | 18692083 6679447 8291058 18648102 18289764 9328219 9022650 9653073 16192314 7440962 1440618 11289319 6482804 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
14.93 | 2444490 16781746 12594235 17522070 19923254 14725611 19164858 19085960 16227642 19739265 16485898 16109766 11834606 11461765 14986274 12705907 14550746 10915739 17562736 15968718 10663392 11421492 19370779 12958197 15619225 16081117 16393943 19416960 11529661 18071297 12392966 17906064 11739529 11287661 10774834 16177239 12540782 12153990 11743745 18713872 19420014 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
14.93 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
14.93 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
14.93 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
14.93 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.02 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.89 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.89 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.96 | 1851702 |
MESH:D004487 |
Edema |
|
resveratrol |
6.59 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.59 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.82 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.84 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
8.84 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.50 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.49 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.49 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.94 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.08 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.76 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.07 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.84 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.89 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.51 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.21 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.98 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.45 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.45 | 15173087 16337965 16785472 16481741 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.60 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.60 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
12.60 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.37 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.81 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.04 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.94 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.50 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.19 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.19 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.59 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.59 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.13 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.14 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.14 | 16598420 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.83 | 16145905 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.95 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.51 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.72 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.72 | 15102660 18337622 15162350 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.28 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.42 | 16244371 16244372 18674790 17875725 16144979 16495754 17888722 18006777 16879835 12587719 16707910 14766674 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.07 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.07 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.82 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.34 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.25 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.43 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.81 | 15340226 12621046 16120746 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
9.81 | 10809021 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
9.81 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
11.93 | 15147373 17606976 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
11.93 | 18180244 17606976 16135485 15147373 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
11.93 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Isoflavones |
4.90 | 17290160 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.78 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.96 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.63 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.92 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.94 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.85 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.83 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.83 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.22 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.72 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.56 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.38 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.44 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.44 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
resveratrol |
4.92 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.92 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
10.81 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.81 | 16624496 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.94 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.25 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.36 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
14.02 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.02 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
14.02 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
14.02 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
9.71 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
9.71 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.98 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.98 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
11.98 | 16985049 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
6.65 | 12970779 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.65 | 18980019 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.08 | 16085563 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.14 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.52 | 16087638 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.14 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.48 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.48 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.48 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.61 | 12587719 16610002 11587558 12969438 19460945 16611625 19784758 19014921 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.16 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
10.46 | 17045692 16603448 15113037 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
10.46 | 19812893 19073162 20405173 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.46 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.46 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.51 | 598648 6587162 3712494 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.51 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.51 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.11 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.18 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.78 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
4.78 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.78 | 17306315 15276417 16712894 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.78 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.71 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.70 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
7.70 | 12854902 12556972 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.21 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.63 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
8.63 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.48 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.16 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
13.85 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
13.85 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
13.85 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
13.85 | 15318939 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.12 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
5.12 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.12 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.48 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.17 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.17 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.29 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.71 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.13 | 18803445 18765137 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.42 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.56 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.70 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.40 | 17164350 17049120 17935668 16490592 14749477 16267019 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.78 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.94 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.10 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.39 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
9.39 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
9.39 | 16456233 17188708 16317513 16525036 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.77 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.77 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.59 | 17141266 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.67 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.73 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.73 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.04 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.04 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.94 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.94 | 20056578 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.68 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.36 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.04 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.04 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
9.32 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.32 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
11.80 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.80 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.80 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.22 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.11 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
8.11 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.31 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.38 | 16436463 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.34 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.94 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
7.41 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Isoflavones |
7.41 | 16562857 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
9.87 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
9.87 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.04 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
7.90 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
7.90 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.90 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.32 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
5.53 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.53 | 15113037 16500647 19003803 16929163 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.60 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.40 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.17 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.39 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.08 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.81 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.08 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.47 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.14 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
15.78 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
15.78 | 11222880 11399792 11896295 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
15.78 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.45 | 15897917 16888761 16729912 16868541 18437689 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
2.45 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.45 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.45 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
2.45 | 17571952 16365062 17374662 17219775 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.45 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.45 | 17804756 15767336 17636462 17718901 17675339 16731767 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.45 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.23 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.46 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.20 | 16882103 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.93 | 18286688 16160472 18722050 15538739 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.13 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.50 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.23 | 16314181 17520802 17058453 16317513 15827377 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.31 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.09 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.91 | 18313854 15625365 17203757 17710206 16767912 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
10.26 | 14601052 16326096 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
10.26 | 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.70 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.06 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.68 | 3137016 15475178 14763951 17978042 11044598 11738929 1511512 16876388 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.26 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
13.26 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.26 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.26 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.48 | 16767912 15625365 17203757 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.86 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.31 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.31 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.46 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 18396642 19084572 16424979 17172411 17522103 16951190 19015929 17498489 18567086 15786421 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.40 | 16321402 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.54 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.07 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.82 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.03 | 6587162 6582329 3712494 1399818 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.03 | 17909728 16010429 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.72 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
9.72 | 16227395 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.15 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.44 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.17 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.17 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.17 | 16712894 11723127 17306315 16452187 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.56 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.89 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
15.46 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
15.46 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
15.46 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.21 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
9.21 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.90 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.34 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.51 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.46 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
10.05 | 16364871 17334414 17638931 17678736 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
10.05 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.17 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.36 | 17120751 |